Lung Tissue Research Consortium
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Chronic Obstructive Pulmonary Disease
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Enrollment
- 247
- Locations
- 4
- Primary Endpoint
- Clinical diagnosis
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
The LTRC will facilitate histopathological research of pulmonary diseases by collecting lung tissues from donors and preparing and distributing collections of tissue specimens to researchers within and outside the LTRC. Collections of specimens will be linked to individual clinical data appropriate to the particular disease. The primary goal of the LTRC is to identify participants with suspected lung cancer or metastatic disease who are willing to provide informed consent for research use of their specimens and data. Secondarily, the LTRC investigators intend to collect clinical data, limited exposure data, physiologic studies, and radiographic studies from these participants.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Adults ages 21 or older who are undergoing lung surgery for suspected malignancy or metastases.
Exclusion Criteria
- •Diagnosis of cystic fibrosis or pulmonary hypertension.
- •Any other condition that, in the judgment of the investigator, precludes participation.
- •Failure to obtain written consent.
Outcomes
Primary Outcomes
Clinical diagnosis
Time Frame: Two months following surgery
A final diagnosis of the participant's lung disease will be rendered by the clinical center PI.